Viatris Inc.: Dyslipidemias trials

The registry lists 16 Dyslipidemias studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 3 1Phase 4 12No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cardiovascular Events Based On Statin Initiation In The ElderlyCompletedNCT01304641Results posted
• Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol LevelsCompletedNCT00673660Results posted
• Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels StudyCompletedNCT00540293Phase 4Results posted
• A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra RiskCompletedNCT00412113Phase 4Results posted
• Africa and Middle East Cardiovascular Epidemiological StudyCompletedNCT01243138
• A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.CompletedNCT00708370Phase 4
• Atorvastatin Study For The Treatment Of High Cholesterol In Patients From ThailandCompletedNCT00647543Phase 4
• A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High CholesterolCompletedNCT00645151Phase 4
• A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)CompletedNCT00644709Phase 4
• A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High CholesterolCompletedNCT00644670Phase 4
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)CompletedNCT00442845Phase 4
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol TargetsCompletedNCT00442325Phase 4
• Caduet in an Untreated Subject PopulationCompletedNCT00332761Phase 4
• Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaCompletedNCT00330785Phase 3
• Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.CompletedNCT00174304Phase 4
• Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient PopulationCompletedNCT00150384Phase 4